ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

JVA Avidus Management Group, Inc.

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Avidus Management Group, Inc. TSXV:JVA TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Asantae announces name change to Avidus Management Group Inc.

31/05/2013 12:06am

PR Newswire (Canada)


Avidus Management Group, Inc. (TSXV:JVA)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Avidus Management Group, Inc. Charts.

VANCOUVER, BC and MESA, AZ, May 30, 2013 /CNW/ - Asantae Holdings International Inc. ("Asantae" or the "Company") (TSX-V: JVA) is pleased to announce that, further to its news release dated May 22, 2013, the Company's name will change from "Asantae Holdings International Inc." to "Avidus Management Group Inc." effective May 31, 2013.

Accordingly, at the opening of trading on the TSX Venture Exchange on Friday, May 31, 2013, the Company will commence trading under its new name and the trading symbol for the Company will change from "JVA" to "AVD".  The new CUSIP number will be 053677100 and the new ISIN number will be CA 0536771003.  The share capital of the Company remains unchanged.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Asantae

Asantae Holdings International Inc. (www.asantae.com) (TSX-V: JVA) is a producer and marketer of innovative nutritional products through direct and network marketing channels. The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.).

This news release may contain forward-looking statements relating to the Company's operations or to the environment in which it operates. Such statements are based on operations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and may be beyond the Company's control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements, including those set forth in the company's regulatory filings. In addition, such statements relate to the date on which they are made and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

SOURCE Asantae Holdings International, Inc

Copyright 2013 Canada NewsWire

1 Year Avidus Management Group, Inc. Chart

1 Year Avidus Management Group, Inc. Chart

1 Month Avidus Management Group, Inc. Chart

1 Month Avidus Management Group, Inc. Chart

Your Recent History

Delayed Upgrade Clock